Jeffrey Maki
Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Angiography | 38 | 2021 | 249 | 7.110 |
Why?
| | Contrast Media | 45 | 2024 | 493 | 6.840 |
Why?
| | Gadolinium | 22 | 2024 | 78 | 4.520 |
Why?
| | Image Enhancement | 23 | 2024 | 198 | 3.540 |
Why?
| | Magnetic Resonance Imaging | 38 | 2024 | 3926 | 3.510 |
Why?
| | Organometallic Compounds | 13 | 2023 | 110 | 3.090 |
Why?
| | Image Interpretation, Computer-Assisted | 13 | 2024 | 295 | 2.910 |
Why?
| | Lymphedema | 6 | 2025 | 23 | 2.230 |
Why?
| | Meglumine | 10 | 2023 | 18 | 2.150 |
Why?
| | Lymphography | 6 | 2023 | 13 | 1.850 |
Why?
| | Renal Artery Obstruction | 10 | 2009 | 30 | 1.590 |
Why?
| | Imaging, Three-Dimensional | 14 | 2023 | 582 | 1.230 |
Why?
| | Gadolinium DTPA | 9 | 2015 | 70 | 1.140 |
Why?
| | Magnetic Resonance Imaging, Cine | 5 | 2015 | 214 | 1.140 |
Why?
| | Lymphatic Vessels | 4 | 2025 | 64 | 1.100 |
Why?
| | Arteries | 4 | 2016 | 261 | 1.100 |
Why?
| | Sensitivity and Specificity | 19 | 2021 | 1998 | 1.100 |
Why?
| | Ferrosoferric Oxide | 3 | 2017 | 24 | 1.050 |
Why?
| | Algorithms | 11 | 2018 | 1849 | 1.000 |
Why?
| | Liver Cirrhosis | 3 | 2014 | 278 | 0.990 |
Why?
| | Water | 5 | 2022 | 451 | 0.990 |
Why?
| | Models, Cardiovascular | 4 | 2016 | 194 | 0.980 |
Why?
| | Prostatic Neoplasms | 2 | 2024 | 972 | 0.980 |
Why?
| | Peripheral Vascular Diseases | 5 | 2009 | 102 | 0.980 |
Why?
| | Renal Artery | 8 | 2021 | 42 | 0.930 |
Why?
| | Pulmonary Embolism | 2 | 2019 | 246 | 0.930 |
Why?
| | Liver Neoplasms | 5 | 2015 | 776 | 0.880 |
Why?
| | Image Processing, Computer-Assisted | 13 | 2023 | 778 | 0.870 |
Why?
| | Lymphatic System | 3 | 2025 | 16 | 0.870 |
Why?
| | Blood Chemical Analysis | 2 | 2016 | 109 | 0.840 |
Why?
| | Liver | 6 | 2023 | 1864 | 0.840 |
Why?
| | Reproducibility of Results | 22 | 2024 | 3416 | 0.820 |
Why?
| | Peliosis Hepatis | 1 | 2023 | 2 | 0.770 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2022 | 55 | 0.720 |
Why?
| | Artificial Intelligence | 2 | 2024 | 389 | 0.710 |
Why?
| | Rest | 1 | 2022 | 126 | 0.690 |
Why?
| | Diagnostic Imaging | 2 | 2022 | 340 | 0.680 |
Why?
| | Aortic Valve Insufficiency | 3 | 2017 | 43 | 0.660 |
Why?
| | Carcinoma, Hepatocellular | 2 | 2015 | 370 | 0.650 |
Why?
| | Mitral Valve Insufficiency | 3 | 2017 | 69 | 0.640 |
Why?
| | Artifacts | 12 | 2019 | 143 | 0.600 |
Why?
| | Blood Flow Velocity | 4 | 2016 | 419 | 0.570 |
Why?
| | Patient-Specific Modeling | 2 | 2016 | 46 | 0.560 |
Why?
| | Humans | 80 | 2025 | 146342 | 0.530 |
Why?
| | Venous Thrombosis | 1 | 2019 | 199 | 0.480 |
Why?
| | Middle Aged | 34 | 2019 | 36619 | 0.450 |
Why?
| | Blood Vessels | 2 | 2016 | 164 | 0.450 |
Why?
| | Computer Simulation | 9 | 2017 | 1014 | 0.440 |
Why?
| | Heterocyclic Compounds | 3 | 2023 | 23 | 0.430 |
Why?
| | Software | 2 | 2024 | 676 | 0.420 |
Why?
| | Phantoms, Imaging | 8 | 2021 | 160 | 0.420 |
Why?
| | Magnetics | 2 | 2016 | 45 | 0.410 |
Why?
| | Lymph Node Excision | 1 | 2015 | 174 | 0.400 |
Why?
| | Radiology Information Systems | 1 | 2014 | 35 | 0.400 |
Why?
| | Male | 41 | 2024 | 73396 | 0.390 |
Why?
| | Medical Records Systems, Computerized | 1 | 2014 | 95 | 0.390 |
Why?
| | Diffusion Magnetic Resonance Imaging | 2 | 2021 | 158 | 0.390 |
Why?
| | User-Computer Interface | 1 | 2014 | 168 | 0.380 |
Why?
| | Lymph Nodes | 1 | 2015 | 511 | 0.360 |
Why?
| | Blood Proteins | 1 | 2013 | 239 | 0.350 |
Why?
| | Documentation | 1 | 2014 | 202 | 0.350 |
Why?
| | Elasticity Imaging Techniques | 1 | 2012 | 59 | 0.340 |
Why?
| | Hemangiosarcoma | 1 | 2012 | 27 | 0.340 |
Why?
| | Aneurysm, False | 1 | 2012 | 46 | 0.340 |
Why?
| | Heart Neoplasms | 1 | 2012 | 56 | 0.340 |
Why?
| | Oxygen | 1 | 2016 | 997 | 0.320 |
Why?
| | Osteitis Deformans | 1 | 2010 | 9 | 0.320 |
Why?
| | Coronary Sinus | 1 | 2010 | 9 | 0.320 |
Why?
| | Heart | 1 | 2014 | 626 | 0.310 |
Why?
| | Anatomy, Cross-Sectional | 1 | 2010 | 11 | 0.310 |
Why?
| | Aged | 24 | 2017 | 26432 | 0.310 |
Why?
| | Cell Membrane | 1 | 2013 | 701 | 0.310 |
Why?
| | Coronary Vessels | 1 | 2012 | 245 | 0.300 |
Why?
| | Heart Septal Defects, Atrial | 1 | 2010 | 58 | 0.300 |
Why?
| | Adult | 26 | 2021 | 41087 | 0.300 |
Why?
| | Prospective Studies | 11 | 2023 | 8123 | 0.290 |
Why?
| | Restraint, Physical | 1 | 2009 | 70 | 0.290 |
Why?
| | Transducers | 1 | 2009 | 26 | 0.290 |
Why?
| | Skull | 1 | 2010 | 162 | 0.290 |
Why?
| | Female | 37 | 2025 | 79499 | 0.280 |
Why?
| | Veins | 2 | 2006 | 68 | 0.280 |
Why?
| | Abdomen | 3 | 1998 | 142 | 0.270 |
Why?
| | Aorta | 2 | 2023 | 440 | 0.260 |
Why?
| | Echocardiography | 3 | 2017 | 645 | 0.260 |
Why?
| | Microcirculation | 4 | 1991 | 142 | 0.260 |
Why?
| | Aorta, Thoracic | 1 | 2010 | 284 | 0.250 |
Why?
| | Hematocrit | 1 | 2006 | 108 | 0.240 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2016 | 2022 | 0.240 |
Why?
| | Respiration | 3 | 2007 | 208 | 0.220 |
Why?
| | Radiology | 1 | 2007 | 175 | 0.220 |
Why?
| | Predictive Value of Tests | 5 | 2017 | 2113 | 0.210 |
Why?
| | Upper Extremity | 1 | 2025 | 114 | 0.200 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2024 | 92 | 0.190 |
Why?
| | Nephrogenic Fibrosing Dermopathy | 2 | 2015 | 8 | 0.190 |
Why?
| | Prostate | 1 | 2024 | 159 | 0.190 |
Why?
| | Activation, Metabolic | 1 | 2022 | 5 | 0.180 |
Why?
| | Injections, Intravenous | 3 | 2019 | 197 | 0.180 |
Why?
| | Carotid Arteries | 2 | 2007 | 206 | 0.180 |
Why?
| | Tomography, X-Ray Computed | 5 | 2018 | 2786 | 0.180 |
Why?
| | Constriction, Pathologic | 2 | 2021 | 240 | 0.180 |
Why?
| | Observer Variation | 4 | 2018 | 356 | 0.180 |
Why?
| | Thorax | 2 | 2019 | 51 | 0.170 |
Why?
| | ROC Curve | 3 | 2014 | 617 | 0.170 |
Why?
| | Angiography, Digital Subtraction | 4 | 2021 | 51 | 0.170 |
Why?
| | Swine | 1 | 2023 | 821 | 0.160 |
Why?
| | Feasibility Studies | 4 | 2019 | 1135 | 0.160 |
Why?
| | Phlebography | 2 | 2019 | 38 | 0.150 |
Why?
| | Motion | 3 | 2009 | 94 | 0.150 |
Why?
| | Monte Carlo Method | 2 | 2017 | 151 | 0.150 |
Why?
| | Brain Mapping | 1 | 2022 | 541 | 0.140 |
Why?
| | Pancreas | 1 | 2021 | 343 | 0.140 |
Why?
| | Radiation Exposure | 1 | 2019 | 62 | 0.140 |
Why?
| | Cardiac Imaging Techniques | 1 | 2017 | 24 | 0.130 |
Why?
| | Pelvis | 1 | 2019 | 129 | 0.130 |
Why?
| | Computed Tomography Angiography | 1 | 2019 | 151 | 0.130 |
Why?
| | Models, Statistical | 2 | 2015 | 669 | 0.130 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 121 | 0.130 |
Why?
| | Total Quality Management | 1 | 2017 | 59 | 0.120 |
Why?
| | Glucose | 1 | 2022 | 1053 | 0.120 |
Why?
| | Computer-Aided Design | 1 | 2016 | 39 | 0.120 |
Why?
| | Injections, Intra-Arterial | 1 | 2016 | 25 | 0.120 |
Why?
| | Radiation Dosage | 2 | 2018 | 193 | 0.120 |
Why?
| | Practice Guidelines as Topic | 2 | 2014 | 1591 | 0.120 |
Why?
| | Surface-Active Agents | 1 | 2017 | 99 | 0.120 |
Why?
| | Breath Holding | 1 | 2015 | 10 | 0.120 |
Why?
| | Arteriovenous Malformations | 1 | 2016 | 34 | 0.120 |
Why?
| | Aged, 80 and over | 6 | 2008 | 8391 | 0.120 |
Why?
| | Extremities | 1 | 2016 | 142 | 0.110 |
Why?
| | Printing, Three-Dimensional | 1 | 2016 | 102 | 0.110 |
Why?
| | Diffusion | 4 | 1991 | 119 | 0.110 |
Why?
| | Prenatal Diagnosis | 1 | 2017 | 190 | 0.110 |
Why?
| | Positron-Emission Tomography | 1 | 2017 | 343 | 0.110 |
Why?
| | Blood | 1 | 2015 | 107 | 0.110 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2016 | 534 | 0.110 |
Why?
| | Sarcoidosis | 1 | 2017 | 164 | 0.110 |
Why?
| | Plasma | 1 | 2016 | 222 | 0.100 |
Why?
| | Single-Blind Method | 1 | 2015 | 313 | 0.100 |
Why?
| | Software Validation | 1 | 2014 | 9 | 0.100 |
Why?
| | Microcomputers | 1 | 2014 | 17 | 0.100 |
Why?
| | Software Design | 1 | 2014 | 25 | 0.100 |
Why?
| | Diagnosis, Differential | 3 | 2016 | 1503 | 0.100 |
Why?
| | Surgery, Computer-Assisted | 1 | 2015 | 87 | 0.100 |
Why?
| | Radiography | 2 | 2014 | 861 | 0.100 |
Why?
| | Magnetic Fields | 1 | 2013 | 24 | 0.100 |
Why?
| | Arthritis, Rheumatoid | 1 | 2023 | 1185 | 0.100 |
Why?
| | Transposition of Great Vessels | 1 | 2014 | 41 | 0.100 |
Why?
| | Electric Impedance | 1 | 2013 | 108 | 0.100 |
Why?
| | Protons | 1 | 2013 | 96 | 0.100 |
Why?
| | Cardiomyopathies | 1 | 2017 | 340 | 0.090 |
Why?
| | Information Storage and Retrieval | 1 | 2014 | 121 | 0.090 |
Why?
| | Drug Design | 1 | 2014 | 180 | 0.090 |
Why?
| | Kidney | 2 | 2012 | 1498 | 0.090 |
Why?
| | Pulmonary Artery | 1 | 2018 | 1116 | 0.090 |
Why?
| | Angiography | 3 | 2004 | 206 | 0.090 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2418 | 0.090 |
Why?
| | Cerebrovascular Circulation | 2 | 1991 | 293 | 0.090 |
Why?
| | Echocardiography, Doppler | 1 | 2012 | 117 | 0.090 |
Why?
| | Elastic Modulus | 1 | 2012 | 121 | 0.090 |
Why?
| | Leg | 2 | 2004 | 246 | 0.080 |
Why?
| | Diagnostic Errors | 1 | 2012 | 178 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2921 | 0.080 |
Why?
| | Cerebral Infarction | 1 | 1991 | 46 | 0.080 |
Why?
| | Carbon Dioxide | 2 | 1991 | 228 | 0.080 |
Why?
| | Animals | 8 | 2023 | 38107 | 0.080 |
Why?
| | Cardiac Valve Annuloplasty | 1 | 2010 | 3 | 0.080 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2010 | 23 | 0.080 |
Why?
| | Equipment Design | 2 | 2009 | 520 | 0.080 |
Why?
| | Tricuspid Valve | 1 | 2010 | 42 | 0.080 |
Why?
| | Prognosis | 2 | 2016 | 4351 | 0.080 |
Why?
| | Time Factors | 5 | 2017 | 7109 | 0.080 |
Why?
| | Bone Remodeling | 1 | 2010 | 71 | 0.080 |
Why?
| | Pericardium | 1 | 2010 | 59 | 0.080 |
Why?
| | Fourier Analysis | 3 | 2007 | 42 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2017 | 3647 | 0.070 |
Why?
| | Guideline Adherence | 1 | 2014 | 594 | 0.070 |
Why?
| | Kidney Failure, Chronic | 1 | 2015 | 589 | 0.070 |
Why?
| | Adolescent | 5 | 2023 | 22557 | 0.070 |
Why?
| | Hypertension, Renal | 1 | 2009 | 15 | 0.070 |
Why?
| | Ventricular Function, Left | 1 | 2012 | 541 | 0.070 |
Why?
| | Spin Labels | 1 | 2009 | 60 | 0.070 |
Why?
| | Equipment Failure Analysis | 1 | 2009 | 124 | 0.070 |
Why?
| | Young Adult | 3 | 2016 | 14330 | 0.070 |
Why?
| | Kidney Diseases | 1 | 2012 | 428 | 0.060 |
Why?
| | Heart Valve Diseases | 1 | 2009 | 151 | 0.060 |
Why?
| | Scattering, Radiation | 1 | 2007 | 98 | 0.060 |
Why?
| | Models, Structural | 3 | 1991 | 40 | 0.060 |
Why?
| | Pentetic Acid | 2 | 1997 | 13 | 0.060 |
Why?
| | Infusions, Intravenous | 2 | 1998 | 432 | 0.060 |
Why?
| | Vena Cava, Inferior | 1 | 2006 | 80 | 0.060 |
Why?
| | Electrocardiography | 1 | 2009 | 667 | 0.060 |
Why?
| | Drug Combinations | 2 | 1997 | 400 | 0.060 |
Why?
| | Brain | 4 | 1991 | 2991 | 0.060 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2006 | 99 | 0.050 |
Why?
| | Vascular Diseases | 1 | 2007 | 252 | 0.050 |
Why?
| | Arterial Occlusive Diseases | 1 | 2004 | 88 | 0.050 |
Why?
| | Lung | 1 | 2017 | 4122 | 0.050 |
Why?
| | Atherosclerosis | 1 | 2007 | 410 | 0.050 |
Why?
| | Indocyanine Green | 1 | 2023 | 43 | 0.050 |
Why?
| | Metacarpophalangeal Joint | 1 | 2023 | 23 | 0.050 |
Why?
| | Tomography, Spiral Computed | 1 | 2002 | 30 | 0.050 |
Why?
| | Hepatic Artery | 1 | 2002 | 53 | 0.050 |
Why?
| | Hypertension, Renovascular | 3 | 2009 | 15 | 0.040 |
Why?
| | Thrombosis | 1 | 2006 | 398 | 0.040 |
Why?
| | Hand | 1 | 2023 | 157 | 0.040 |
Why?
| | Kidney Neoplasms | 1 | 2006 | 419 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2017 | 17438 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2021 | 218 | 0.040 |
Why?
| | Rats | 5 | 1991 | 5586 | 0.040 |
Why?
| | Neck | 1 | 1998 | 107 | 0.030 |
Why?
| | Rats, Inbred Strains | 3 | 1991 | 316 | 0.030 |
Why?
| | Fetal Organ Maturity | 1 | 2017 | 13 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1888 | 0.030 |
Why?
| | Forms and Records Control | 1 | 2017 | 21 | 0.030 |
Why?
| | Ultrasonography | 2 | 2014 | 788 | 0.030 |
Why?
| | Head | 1 | 1998 | 125 | 0.030 |
Why?
| | Heart Failure | 1 | 2010 | 2329 | 0.030 |
Why?
| | Technology Assessment, Biomedical | 1 | 2016 | 44 | 0.030 |
Why?
| | Rheology | 2 | 2002 | 94 | 0.030 |
Why?
| | Ferric Compounds | 1 | 1997 | 55 | 0.030 |
Why?
| | Safety | 1 | 1998 | 347 | 0.030 |
Why?
| | United States | 1 | 2014 | 16136 | 0.030 |
Why?
| | Efficiency, Organizational | 1 | 2017 | 144 | 0.030 |
Why?
| | Liver Transplantation | 1 | 2002 | 751 | 0.030 |
Why?
| | Linear Models | 2 | 2002 | 857 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 1998 | 640 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2017 | 5439 | 0.030 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2015 | 74 | 0.030 |
Why?
| | Kidney Function Tests | 1 | 2015 | 156 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2010 | 11821 | 0.030 |
Why?
| | Physical Examination | 1 | 2016 | 237 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2017 | 970 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2017 | 627 | 0.030 |
Why?
| | Surgical Procedures, Operative | 1 | 2017 | 307 | 0.020 |
Why?
| | Carotid Artery Diseases | 1 | 2013 | 70 | 0.020 |
Why?
| | Gestational Age | 1 | 2017 | 990 | 0.020 |
Why?
| | Cerebrovascular Disorders | 1 | 2013 | 103 | 0.020 |
Why?
| | Contraindications | 1 | 2012 | 88 | 0.020 |
Why?
| | Fetus | 1 | 2017 | 800 | 0.020 |
Why?
| | Body Water | 1 | 1991 | 23 | 0.020 |
Why?
| | Lasers | 1 | 1991 | 127 | 0.020 |
Why?
| | Acetone | 1 | 1991 | 11 | 0.020 |
Why?
| | Edetic Acid | 1 | 1991 | 47 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1827 | 0.020 |
Why?
| | Gels | 1 | 1991 | 86 | 0.020 |
Why?
| | Dextrans | 1 | 1991 | 83 | 0.020 |
Why?
| | Rats, Inbred F344 | 1 | 1991 | 266 | 0.020 |
Why?
| | Muscles | 1 | 1991 | 330 | 0.020 |
Why?
| | Corpus Striatum | 1 | 1991 | 181 | 0.020 |
Why?
| | Child | 1 | 2010 | 22693 | 0.020 |
Why?
| | Stroke Volume | 1 | 2012 | 652 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 1991 | 1041 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2012 | 745 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 1991 | 485 | 0.020 |
Why?
| | Whole Body Imaging | 1 | 2007 | 29 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 3712 | 0.020 |
Why?
| | Leiomyosarcoma | 1 | 2006 | 30 | 0.010 |
Why?
| | Carotid Stenosis | 1 | 2007 | 103 | 0.010 |
Why?
| | Myocardial Infarction | 1 | 2013 | 1215 | 0.010 |
Why?
| | Clinical Protocols | 1 | 2006 | 282 | 0.010 |
Why?
| | Reference Standards | 1 | 2004 | 176 | 0.010 |
Why?
| | Pregnancy | 1 | 2017 | 7230 | 0.010 |
Why?
| | Models, Biological | 1 | 1991 | 1761 | 0.010 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2002 | 17 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2002 | 426 | 0.010 |
Why?
| | Portal Vein | 1 | 2002 | 123 | 0.010 |
Why?
| | Risk Factors | 1 | 2015 | 10921 | 0.010 |
Why?
| | Movement | 1 | 2002 | 290 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 2002 | 507 | 0.010 |
Why?
| | Liver Diseases | 1 | 2002 | 304 | 0.010 |
Why?
| | Adenocarcinoma | 1 | 2006 | 927 | 0.010 |
Why?
| | Models, Theoretical | 1 | 2002 | 561 | 0.010 |
Why?
| | Half-Life | 1 | 1997 | 157 | 0.010 |
Why?
| | Reference Values | 1 | 1997 | 796 | 0.010 |
Why?
| | Death | 1 | 1991 | 129 | 0.000 |
Why?
| | Body Temperature | 1 | 1991 | 228 | 0.000 |
Why?
| | Cell Death | 1 | 1991 | 379 | 0.000 |
Why?
|
|
Maki's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|